MAPK3 and chronic myelogenous leukemia, BCR-ABL1 positive: Our data is in agreement with the report by others that ERK1/2 is activated by cell adhesion leading to cell survival and inhibition of which leads to apoptosis in CML as well as multiple myeloma cells32, 33.